PATENT CLAIM ANALYSIS

Application Number: 16099088
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["424", "472000"]

Abstract:
A stable tablet-in-tablet pharmaceutical composition having fixed dose combinations of cyclophosphamide and capecitabine and one or more pharmaceutically acceptable excipient. As disclosed is a process for the preparation thereof, and a method their use in treating cancer diseases.

Claim (Index 7):
The stable tablet-in-tablet pharmaceutical composition according to  claim 2 , wherein the pharmaceutically acceptable excipients can be selected form one or more diluents, one or more binders, one or more disintegrants, one or more glidants, one or more lubricants, one or more plasticizer, one or more opacifying agent, one or more colorants and combinations thereof.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 98.0
- Lexical Diversity: 1.10811
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15512946', '12682825', '11475252', '11930644', '13643386']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7123393582952645
- 35 USC 102 Novelty (BERT): 0.5092612172677234
- Combined Prediction Score: 0.6920315441925105
- Mean Citation Score: 230.019742
- Max Citation Score: 262.29202000000004
- Similarity Product: 195.8679096933269

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test